Cargando…
A unique presentation of a renal clear cell carcinoma with atypical metastases
INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “inc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446666/ https://www.ncbi.nlm.nih.gov/pubmed/25911241 http://dx.doi.org/10.1016/j.ijscr.2015.03.009 |
_version_ | 1782373476795940864 |
---|---|
author | Staderini, F. Cianchi, F. Badii, B. Skalamera, I. Fiorenza, G. Foppa, C. Qirici, E. Perigli, G. |
author_facet | Staderini, F. Cianchi, F. Badii, B. Skalamera, I. Fiorenza, G. Foppa, C. Qirici, E. Perigli, G. |
author_sort | Staderini, F. |
collection | PubMed |
description | INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “incidental findings” and those with advanced metastatic disease. PRESENTATION OF CASE: A 70-year-old male with multiple indolent subcutaneous masses underwent colonoscopy after a positive fecal screening test for colorectal carcinoma. A rectal lesion was discovered but biopsy was negative. CT scan revealed advanced renal cancer involving the peritoneal cavity, retroperitoneum and lung. Biopsy of subcutaneous masses confirmed the suspected metastases. The patient underwent surgery (an open left nephrectomy with rectosigmoid resection and metastases debulking) because of a high risk of bowel obstruction and increasing anemia. After three years of multi-targeted therapy and follow-up, the patient is still asymptomatic and in good general condition. DISCUSSION: Treatment of metastatic renal cancer is still controversial even if more than 30% of patients have metastasis at the time of diagnosis. Recently introduced targeted therapies are encouraging but still present problems with side effects and an unlimited period of efficacy. Although there is no consensus, several studies and guidelines consider metastasectomy to be a valid option. CONCLUSION: Recent series highlight surgery as a key-point in the management of advanced renal clear cell carcinoma. Our case demonstrates the validity of a surgical strategy supported by a multidisciplinary approach. |
format | Online Article Text |
id | pubmed-4446666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-44466662015-05-29 A unique presentation of a renal clear cell carcinoma with atypical metastases Staderini, F. Cianchi, F. Badii, B. Skalamera, I. Fiorenza, G. Foppa, C. Qirici, E. Perigli, G. Int J Surg Case Rep Case Report INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “incidental findings” and those with advanced metastatic disease. PRESENTATION OF CASE: A 70-year-old male with multiple indolent subcutaneous masses underwent colonoscopy after a positive fecal screening test for colorectal carcinoma. A rectal lesion was discovered but biopsy was negative. CT scan revealed advanced renal cancer involving the peritoneal cavity, retroperitoneum and lung. Biopsy of subcutaneous masses confirmed the suspected metastases. The patient underwent surgery (an open left nephrectomy with rectosigmoid resection and metastases debulking) because of a high risk of bowel obstruction and increasing anemia. After three years of multi-targeted therapy and follow-up, the patient is still asymptomatic and in good general condition. DISCUSSION: Treatment of metastatic renal cancer is still controversial even if more than 30% of patients have metastasis at the time of diagnosis. Recently introduced targeted therapies are encouraging but still present problems with side effects and an unlimited period of efficacy. Although there is no consensus, several studies and guidelines consider metastasectomy to be a valid option. CONCLUSION: Recent series highlight surgery as a key-point in the management of advanced renal clear cell carcinoma. Our case demonstrates the validity of a surgical strategy supported by a multidisciplinary approach. Elsevier 2015-04-09 /pmc/articles/PMC4446666/ /pubmed/25911241 http://dx.doi.org/10.1016/j.ijscr.2015.03.009 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Staderini, F. Cianchi, F. Badii, B. Skalamera, I. Fiorenza, G. Foppa, C. Qirici, E. Perigli, G. A unique presentation of a renal clear cell carcinoma with atypical metastases |
title | A unique presentation of a renal clear cell carcinoma with atypical metastases |
title_full | A unique presentation of a renal clear cell carcinoma with atypical metastases |
title_fullStr | A unique presentation of a renal clear cell carcinoma with atypical metastases |
title_full_unstemmed | A unique presentation of a renal clear cell carcinoma with atypical metastases |
title_short | A unique presentation of a renal clear cell carcinoma with atypical metastases |
title_sort | unique presentation of a renal clear cell carcinoma with atypical metastases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446666/ https://www.ncbi.nlm.nih.gov/pubmed/25911241 http://dx.doi.org/10.1016/j.ijscr.2015.03.009 |
work_keys_str_mv | AT staderinif auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT cianchif auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT badiib auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT skalamerai auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT fiorenzag auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT foppac auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT qiricie auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT periglig auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT staderinif uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT cianchif uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT badiib uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT skalamerai uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT fiorenzag uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT foppac uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT qiricie uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases AT periglig uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases |